ALPS ADVISORS INC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 60 filers reported holding XENON PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$2,294,678
+0.2%
58,853
+10.6%
0.02%0.0%
Q1 2024$2,290,260
-2.1%
53,200
+4.8%
0.02%
-11.1%
Q4 2023$2,338,927
+44.6%
50,780
+7.2%
0.02%
+38.5%
Q3 2023$1,617,442
-10.1%
47,349
+1.3%
0.01%
-18.8%
Q2 2023$1,798,836
+21.0%
46,723
+12.5%
0.02%
+23.1%
Q1 2023$1,486,287
-11.0%
41,528
-2.0%
0.01%
-13.3%
Q4 2022$1,670,689
+36.3%
42,371
+24.8%
0.02%
+25.0%
Q3 2022$1,226,000
+28.0%
33,959
+7.8%
0.01%
+33.3%
Q2 2022$958,000
-48.6%
31,498
-47.2%
0.01%
-57.1%
Q4 2021$1,865,000
+142.2%
59,702
+18.4%
0.02%
+200.0%
Q3 2021$770,000
-23.4%
50,415
-6.6%
0.01%
-22.2%
Q2 2021$1,005,000
-11.4%
53,959
-14.8%
0.01%
-18.2%
Q1 2021$1,134,000
+16.5%
63,331
+0.1%
0.01%0.0%
Q4 2020$973,000
+97.0%
63,254
+41.7%
0.01%
+57.1%
Q3 2020$494,000
-17.4%
44,624
-6.5%
0.01%
-12.5%
Q2 2020$598,000
+29.2%
47,704
-7.1%
0.01%
+100.0%
Q3 2019$463,000
-12.8%
51,356
-4.7%
0.00%0.0%
Q2 2019$531,000
-14.2%
53,888
-11.6%
0.00%0.0%
Q1 2019$619,000
+69.6%
60,964
+5.5%
0.00%
+33.3%
Q4 2018$365,00057,7960.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,754,266$107,388,8317.33%
Altium Capital Management LP 360,600$14,059,7945.74%
Affinity Asset Advisors, LLC 994,227$38,764,9114.47%
First Light Asset Management, LLC 1,306,260$50,931,0774.46%
Nan Fung Group Holdings Ltd 106,680$4,159,4534.44%
Ally Bridge Group (NY) LLC 169,369$6,603,6973.93%
TLS Advisors LLC 32,956$1,2853.22%
BRAIDWELL LP 2,560,573$99,836,7413.13%
Paradigm Biocapital Advisors LP 2,043,280$79,667,4873.05%
BRIDGER MANAGEMENT, LLC 146,800$5,723,7322.94%
View complete list of XENON PHARMACEUTICALS INC shareholders